Don Rockey to Adrenergic beta-Antagonists
This is a "connection" page, showing publications Don Rockey has written about Adrenergic beta-Antagonists.
Connection Strength
2.484
-
Editorial: non-selective beta blockers-in and out of circulation. Authors' reply. Aliment Pharmacol Ther. 2021 03; 53(5):634-635.
Score: 0.665
-
An Update: Portal Hypertensive Gastropathy and Colopathy. Clin Liver Dis. 2019 11; 23(4):643-658.
Score: 0.599
-
The Beneficial Effect of Beta-Blockers in Patients With Cirrhosis, Portal Hypertension and Ascites. Am J Med Sci. 2016 Feb; 351(2):169-76.
Score: 0.468
-
Therapy for primary prophylaxis of varices: and, the winner is...? Hepatology. 2003 Feb; 37(2):473-5; discussion 475-6.
Score: 0.190
-
Letter: Confounders and outcomes in studies of beta-blockers in liver disease-role of PPIs? Authors' reply. Aliment Pharmacol Ther. 2021 07; 54(1):91.
Score: 0.170
-
Non-selective beta-blocker use in cirrhotic patients is associated with a reduced likelihood of hospitalisation for infection. Aliment Pharmacol Ther. 2021 02; 53(3):418-425.
Score: 0.164
-
Portal hypertensive gastropathy: a review. Liver Int. 2010 Sep; 30(8):1094-102.
Score: 0.079
-
Pharmacologic therapy for gastrointestinal bleeding due to portal hypertension and esophageal varices. Curr Gastroenterol Rep. 2006 Feb; 8(1):7-13.
Score: 0.058
-
Review article: controversies surrounding the use of carvedilol and other beta blockers in the management of portal hypertension and cirrhosis. Aliment Pharmacol Ther. 2023 Mar; 57(5):454-463.
Score: 0.047
-
Gastroesophageal variceal hemorrhage. N Engl J Med. 2001 Aug 30; 345(9):669-81.
Score: 0.043